constipation%20in%20adults%20-%20chronic%20functional
CONSTIPATION IN ADULTS - CHRONIC FUNCTIONAL
Constipation is an unsatisfactory defecation distinguished by difficult stool passage, infrequent stools or both.
Difficult stool passage may include straining, feeling of difficulty in passing stool, incomplete evacuation, lumpy/hard stools, prolonged time to defecate, need for manual maneuver to pass stool, abdominal discomfort and feeling of anorectal blockade.
Chronic constipation is considered when symptoms of constipation have existed ≥3 months.
Symptoms of chronic constipation may be due to dysfunction of intestinal motility, visceral sensitivity, anorectal musculature or the enteric nervous system.

Patient Education

  • Engage in regular exercise
  • Inform patient that therapy is comprehensive in order to restore the defecation physiology
  • Reassure and explain about normal bowel habits
    • Encourage patients to defecate when colonic activity is highest (eg upon waking, after meals)

Lifestyle Modification

Dietary Modification

  • Patients should be advised to gradually increase their soluble dietary fiber
    • If possible, dietary fiber via fruits, vegetables and whole grains should be increased to 20-30 g/day
    • If this is not effective, commercial fiber supplements (bulk-producing laxatives) may be added, avoid if bloating is present
  • Patients may be encouraged to maintain adequate hydration, though increased fluid intake does not appear to relieve chronic constipation except in those who are dehydrated
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

28 Apr 2017
Silymarin does not appear to be significantly better than placebo in reducing disease activity by 30 percent or more in patients with nonalcoholic steatohepatitis (NASH), according to the results of a trial.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.